We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Microwave Radiation Can Kill Breast Cancer Cells

By HospiMedica staff writers
Posted on 03 Jan 2001
In a phase I clinical trial, researchers found that one to three weeks following a single treatment by a new microwave radiation system, advanced breast cancer tumors typically were reduced in size or destroyed by about 50% in eight out of 10 patients. Phase II clinical trials will now be conducted.

In the procedure, two needle probes are used to sense and measure parameters during treatment. The focused microwave radiation does not heat the skin but heats the cancer cells to about 1150 F and kills them. Breast cancer cells have a high water content, around 80%, while healthy breast tissue contains only 20-60%. The new system has the potential to reduce or eliminate the use of conventional radiation. In the phase II trials, more than 100 women will receive microwave thermotherapy to treat cancer cells. The microwave technology has been licensed to Celsion Corp. (Columbia, MD, USA) by the Massachusetts Institute of Technology (Cambridge, MA, USA).

The new technique was invented by Alan J. Fenn, a senior staff member of MIT's Air Defense Technology Division, based on research he had conducted on radar anti-jamming technology to detect missiles from space-borne satellites. "This is an out-patient procedure,” said Dr. Fenn. "Patients treated in the phase I trial went home with only one or two tiny band aids.”



Related Links:
Celsion

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Hand Fixation Device
Hand Fixation Device
New
MRI System
Ingenia Prodiva 1.5T CS

Latest Patient Care News

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization